Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 208 citing Havlir: Viral dynamics of HIV: implications for drug development and therapeutic strategies. (0.11 sec) 

A controlled trial of two nucleoside analogues plus indinavir in persons with human …

- mrc.ac.za [PDF] 
SM Hammer, KE Squires, MD Hughes, JM … - New England Journal …, 1997 - content.nejm.org
Methods A total of 1156 patients not previously treated with lamivudine or protease inhibitors
were stratified according to CD4 cell count (50 or fewer vs. 51 to 200 cells per cubic
millimeter) and randomly assigned to one of two daily regimens: 600 mg of zidovudine ...
Cited by 1144 - Related articles - BL Direct - All 12 versions

Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: …

- sbgrid.org [PDF] 
H Huang, R Chopra, GL Verdine, SC Harrison - Science, 1998 - sciencemag.org
A combinatorial disulfide cross-linking strategy was used to prepare a stalled complex of human
immunodeficiency virus-type 1 (HIV-1) reverse transcriptase with a DNA template:primer and
a deoxynucleoside triphosphate (dNTP), and the crystal structure of the complex was ...
Cited by 869 - Related articles - BL Direct - All 17 versions

Antiretroviral therapy for HIV infection in 1996. Recommendations of an …


CC Carpenter, MA Fischl, SM Hammer, MS Hirsch, DM … - Jama, 1996 - Am Med Assoc
OBJECTIVE--To provide clinical recommendations for antiretroviral therapy for human immunodeficiency
virus (HIV) disease with currently (mid 1996) available drugs. When to start therapy, what to start
with, when to change, and what to change to were addressed. PARTICIPANTS--A 13- ...
Cited by 542 - Related articles - BL Direct - All 5 versions

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective …

- pnas.org
M Baba, O Nishimura, N Kanzaki, M … - Proceedings of the …, 1999 - National Acad Sciences
The β-chemokine receptor CCR5 is considered to be an attractive target for inhibition of
macrophage-tropic (CCR5-using or R5) HIV-1 replication because individuals having a nonfunctional
receptor (a homozygous 32-bp deletion in the CCR5 coding region) are apparently ...
Cited by 507 - Related articles - BL Direct - All 9 versions

Mortality, CD4 cell count decline, and depressive symptoms among HIV- …


JR Ickovics, ME Hamburger, D Vlahov, EE … - Jama, 2001 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context The impact of depression on morbidity and ...
Cited by 285 - Related articles - BL Direct - All 6 versions

The polymerase L528M mutation cooperates with nucleotide binding-site …

- nih.gov
SK Ono, N Kato, Y Shiratori, J Kato, T Goto, … - Journal of Clinical …, 2001 - Am Soc Clin Investig
After receiving lamivudine for 3 years to treat chronic hepatitis B, 67–75% of patients develop
B-domain L528M, C-domain M552I, or M552V mutations in the HBV polymerase that render
hepatitis B virus (HBV) drug-resistant. The aim of this study was to evaluate the influence ...
Cited by 217 - Related articles - BL Direct - All 5 versions

The Relationship between Serum Human Immunodeficiency Virus Type 1 (HIV-l) …


LM Mofenson, J Korelitz, WA Meyer III, J Bethel, K … - The Journal of infectious …, 1997 - jstor.org
The Relationship between Serum Human Immunodeficiency Virus Type 1 ... (HIV-l) RNA
Level, CD4 Lymphocyte Percent, and Long-Term Mortality Risk ... Lynne M. Mofenson, James
Korelitz, William A. Meyer III, James Bethel, Kenneth Rich, Savita Pahwa, John Moye, Jr., ...
Cited by 214 - Related articles - BL Direct - All 4 versions

In vivo compartmentalization of human immunodeficiency virus: evidence from the …

- nih.gov [PDF] 
JK Wong, CC Ignacio, F Torriani, D Havlir, NJ … - The Journal of …, 1997 - jvi.highwire.org
Page 1. J OURNAL OF V IROLOGY , 0022-538X/97/$04.00 0 Mar. 1997, p. 2059–2071 Vol.
71, No. 3 Copyright 1997, American Society for Microbiology In Vivo Compartmentalization of
Human Immunodeficiency Virus: Evidence from the Examination of pol ...
Cited by 188 - Related articles - BL Direct - All 8 versions

Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral …


JK Wong, HF Günthard, DV Havlir, ZQ … - Proceedings of the …, 1997 - National Acad Sciences
Potent antiretroviral therapy can reduce plasma HIV RNA levels below the threshold of detection
for periods of a year or more. The magnitude of HIV RNA reduction in the lymphoid tissue in patients
with suppression of HIV RNA levels in plasma beyond 6 months has not been ...
Cited by 184 - Related articles - BL Direct - All 10 versions

Impact of adherence and highly active antiretroviral therapy on survival in HIV- …


PG de Olalla, H Knobel, A Carmona, A … - JAIDS Journal of …, 2002 - pdfs.journals.lww.com
*Epidemiology Service, Municipal Institute of Public Health of Barcelona, and Autónoma University
of Barcelona, Spain; and †Department of Internal Medicine-Infectious Diseases and ‡Service
of Hospital Pharmacy, Hospital del Mar of Barcelona, Barcelona, Spain.
Cited by 161 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google